Allogeneic Cell Therapy Market Size, Share & Trends Analysis Report By Type of Cell Therapy (Virus-Specific T-Cell, Stem Cell, Regulatory T-Cell), By Source of Cell, By Target Indication, By Therapeutic Area, Region And Segment Forecasts, 2023-2031

Chapter 1.Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2.Executive Summary

Chapter 3.Global Allogeneic Cell Therapy Market Snapshot

Chapter 4.Global Allogeneic Cell Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5.Market Segmentation 1: By Type of Cell Therapy Estimates & Trend Analysis
5.1. By Type of Cell Therapy & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type of Cell Therapy:
5.2.1. Virus-Specific T-Cell
5.2.2. Stem Cell
5.2.3. Regulatory T-Cell

Chapter 6.Market Segmentation 2: By Source of Cell Estimates & Trend Analysis
6.1. By Source of Cell & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Type By Source of Cell:
6.2.1. Peripheral Blood
6.2.2. Bone Marrow
6.2.3. Umbilical Cord Blood
6.2.4. Adipose Tissue
6.2.5. Placenta

Chapter 7.Market Segmentation 3: By Target Indication Estimates & Trend Analysis
7.1. By Target Indication & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Type By Target Indication:
7.2.1. Bone Disorder
7.2.2. Critical Limb Ischemia
7.2.3. Crohn’s Disease
7.2.4. Diabetic Foot Ulcer
7.2.5. Graft versus Host Disease
7.2.6. Leukemia
7.2.7. Lymphoma
7.2.8. Myelodysplastic Syndrome
7.2.9. Cytomegalovirus Infection
7.2.10. Others

Chapter 8.Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
8.1. By Therapeutic Area & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following Type By Therapeutic Area:
8.2.1. Oncological Disorders
8.2.2. Neurological Disorders
8.2.3. Musculoskeletal Disorder
8.2.4. Autoimmune / Inflammatory Disorders
8.2.5. Post-Transplant Infections

Chapter 9.Allogeneic Cell Therapy Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Type of Cell Therapy, 2023-2031
9.1.2. North America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Source of Cell, 2023-2031
9.1.3. North America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Indication, 2023-2031
9.1.4. North America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2023-2031
9.1.5. North America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
9.1.5.1. U.S.
9.1.5.2. Canada

9.2. Europe
9.2.1. Europe Allogeneic Cell Therapy Market revenue (US$ Million) by By Type of Cell Therapy, 2023-2031
9.2.2. Europe Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Source of Cell, 2023-2031
9.2.3. Europe Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Indication, 2023-2031
9.2.4. Europe Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2023-2031
9.2.5. Europe Allogeneic Cell Therapy Market revenue (US$ Million) by country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe

9.3. Asia Pacific
9.3.1. Asia Pacific Allogeneic Cell Therapy Market revenue (US$ Million) by By Type of Cell Therapy, 2023-2031
9.3.2. Asia Pacific Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Source of Cell, 2023-2031
9.3.3. Asia Pacific Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Indication, 2023-2031
9.3.4. Asia Pacific Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2023-2031
9.3.5. Asia Pacific Allogeneic Cell Therapy Market revenue (US$ Million) by country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific

9.4. Latin America
9.4.1. Latin America Allogeneic Cell Therapy Market revenue (US$ Million) by By Type of Cell Therapy, 2023-2031
9.4.2. Latin America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Source of Cell, 2023-2031
9.4.3. Latin America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Indication, 2023-2031
9.4.4. Latin America Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2023-2031
9.4.5. Latin America Allogeneic Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America

9.5. Middle East & Africa
9.5.1. Middle East & Africa Allogeneic Cell Therapy Market revenue (US$ Million) by By Type of Cell Therapy, (US$ Million)
9.5.2. Middle East & Africa Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Source of Cell, 2023-2031
9.5.3. Middle East & Africa Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Indication, 2023-2031
9.5.4. Middle East & Africa Allogeneic Cell Therapy Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2023-2031
9.5.5. Middle East & Africa Allogeneic Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA

Chapter 10.Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. TCR² Therapeutics
10.2.2. TiGenix (Takeda)
10.2.3. Adaptimmune Therapeutics plc,
10.2.4. Adicet Bio, Inc.,
10.2.5. Allogene Therapeutics,
10.2.6. Allogene Therapeutics,
10.2.7. Artiva Biotherapeutic,
10.2.8. Atara Biotherapeutics,
10.2.9. Athersys, Inc.,
10.2.10. BioCardia Inc.,
10.2.11. Bluebird Bio,
10.2.12. BlueRock Therapeutics LP,
10.2.13. Bone Therapeutics,
10.2.14. Capricor Therapeutics,
10.2.15. Cell2Cure,
10.2.16. Cellectis,
10.2.17. Cellenkos,
10.2.18. Cellular Biomedicine Group,
10.2.19. Celularity,
10.2.20. Celyad,
10.2.21. Century Therapeutics,
10.2.22. CHABiotech,
10.2.23. CRISPR Therapeutics,
10.2.24. Cynata Therapeutics,
10.2.25. Cyto Therapeutics Pty Limited,
10.2.26. Fate Therapeutics,
10.2.27. Fate Therapeutics,
10.2.28. Fundamenta Therapeutics,
10.2.29. GammaDelta Therapeutics Limited,
10.2.30. GC Cell,
10.2.31. Hope Biosciences,
10.2.32. Immunity Bio,
10.2.33. Lineage Cell Therapeutics, Inc.,
10.2.34. MEDIPOST,
10.2.35. Mesoblast Ltd,
10.2.36. Nanjing Bioheng Biotech,
10.2.37. NantKwest,
10.2.38. Nkarta, Inc.,
10.2.39. Orca Bio,
10.2.40. Organogenesis Inc.,
10.2.41. Osiris Therapeutics, Inc.,
10.2.42. Pluristem Therapeutics Inc,
10.2.43. Poseida Therapeutics
10.2.44. Regeneus,
10.2.45. Stemedica Cell Technologies, Inc.,
10.2.46. Stempeutics

Global Allogeneic Cell Therapies Market Segmentation:

Global Allogeneic Cell Therapies Market Revenue (US$ Mn) by Type of Cell Therapy

• Virus-Specific T-Cell
• Stem Cell
• Regulatory T-Cell

Global Allogeneic Cell Therapies Market Revenue (US$ Mn) Based on Source of Cell

• Peripheral Blood
• Bone Marrow
• Umbilical Cord Blood
• Adipose Tissue
• Placenta

Global Allogeneic Cell Therapies Market Revenue (US$ Mn) Based on Target Indication

• Bone Disorder
• Critical Limb Ischemia
• Crohn’s Disease
• Diabetic Foot Ulcer
• Graft versus Host Disease
• Leukemia
• Lymphoma
• Myelodysplastic Syndrome
• Cytomegalovirus Infection
• Others

Global Allogeneic Cell Therapies Market Revenue (US$ Mn) Based on Therapeutic Area

• Oncological Disorders
• Neurological Disorders
• Musculoskeletal Disorder
• Autoimmune / Inflammatory Disorders
• Post-Transplant Infections

Global Allogeneic Cell Therapies Market Revenue (US$ Mn) Based on Region

Europe Allogeneic Cell Therapies Market Revenue (US$ Mn) by Country

• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

North America Allogeneic Cell Therapies Market Revenue (US$ Mn) by Country

• U.S.
• Canada

Asia Pacific Allogeneic Cell Therapies Market Revenue (US$ Mn) by Country

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Allogeneic Cell Therapies Market Revenue (US$ Mn) by Country

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Allogeneic Cell Therapies Market Revenue (US$ Mn) by Country

• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.